TY  - GEN
AU  - Gupta,R
AU  - Raviglione,M C
AU  - Espinal,M A
TI  - Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?
SN  - 1027-3719
PY  - 2002///0730
KW  - Antitubercular Agents
KW  - therapeutic use
KW  - Government Programs
KW  - trends
KW  - Humans
KW  - International Cooperation
KW  - Isoniazid
KW  - National Health Programs
KW  - Practice Guidelines as Topic
KW  - Rifampin
KW  - Tuberculosis, Multidrug-Resistant
KW  - drug therapy
KW  - World Health Organization
N1  - Publication Type: Journal Article; Review
ER  -